As expected, DDR1 overexpression compromised EFL1-induced pharmacological effects on liver dysfunction, ascites, body weight, tumor weight, tumor volume and tumor morphology (Figure 5D–5G and Figure 6A–6E). The gene discussed is EFL1; the disease is neoplasm.